Skip to main content
Equibles
HGYN logo

HGYN · Hong Yuan Holding Group · Metrics

Track HGYN — free

Use HGYN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HGYN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.03 At close · Oct 21
Rebalance outlook locked
Going-concern doubt — flagged Sep 18, 2026

Substantial doubt about the company's ability to continue as a going concern.

“we had a net loss of $187,750 for the six months ended June 30, 2026 and a net income of $67,542 for the six months ended June 30, 2025, and had a working capital deficit of $174,082 as of June 30, 2026, which raise substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Sep 18, 2026
Market Cap
$2.20M
Shares
74.64M
Volume · Oct 21 25K Avg daily vol (3M) 22.59K

HGYN metrics

56 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.03
Market cap
$2.20M

Price action

20 metrics
Price change (1W)
-20.5%
Price change (30D)
-20.3%
Price change (3M)
+6.5%
Price change (6M)
-70.5%
Price change (YTD)
-22.4%
Price change (1Y)
-24.4%
Trailing year
Price change (5Y)
-86.0%
52-week high
$0.15
52-week low
$0.02
Change from 52-week high
-80.3%
Change from 52-week low
+47.5%
Annualized volatility
439.6%
Annualized volatility (3M)
—
Beta
-0.4
RSI (14D)
40.8
Price vs SMA 50
-24.4%
Price vs SMA 200
-50.6%
Avg volume (3M)
21,723
Relative volume
0.2
Average dollar volume
$903

Company

3 metrics
Sector
Industrials
Industry
Integrated Freight & Logistics
Shares outstanding
74.64M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.6×
reciprocal yield 28.0%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-4.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
60.8%
Operating margin
-15.3%
Trailing 12 months
Net margin
-16.2%
Gross profit (TTM)
$374,824
Operating profit (TTM)
−$94,576
Net income (TTM)
−$99,820
Trailing 12 months
Diluted EPS (TTM)
$0.00
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.01
Gross profit per diluted share (TTM)
$0.01
Operating profit per diluted share (TTM)
$0.00
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$0.00
Operating cash flow per diluted share (TTM)
$0.00
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.00

Growth

11 metrics
Revenue growth YoY
-71.5%
Year over year
Net income growth YoY
-414.2%
Revenue (TTM)
$616,307
Trailing 12 months
EPS growth YoY
-400.0%
Shares change YoY
+0.0%
Year over year
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-15.8%
Debt / equity
—
Current ratio
0.8
EBITDA (TTM)
−$11.83M
Free cash flow (TTM)
—
Quick ratio
0.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$13,365
Total assets
$632,778
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$37,819
Capital expenditures (TTM)
$5,000
R&D (TTM)
$396,000
SG&A (TTM)
$12.15M
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1324759